Drug Type Small molecule drug |
Synonyms NAI 003, NAI003 |
Target |
Action modulators |
Mechanism IRE1 modulators(Serine/threonine-protein kinase/endoribonuclease IRE1 modulators), PDIA6 modulators(protein disulfide isomerase family A member 6 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | China | 01 May 2025 | |
Neoplasms | Preclinical | China | 28 Apr 2025 |